CCM and Implementation of Guideline-Directed Medical Therapy in Patients With Heart Failure (Fix-GDMT-HF)
Condition(s) studied
Study summary
The primary objective of this study is to evaluate the impact of Cardiac Contractility Modulation (CCM) therapy on the initiation and up-titration of Guideline-Directed Medical Therapy (GDMT) in patients with heart failure (HF). This will be assessed by the change in Quad Medication Score (QMS) from baseline (pre-CCM) to 6-month following post-CCM device implant.
Eligibility
Primary outcome measure(s)
- Change in Quad Medication Score — 6 month
Change in the Quad Medication Score (QMS) from baseline (pre-CCM) to 6-month follow-up (post-CCM) of the Optimizer device implant
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Gemelli University Hospital | Rome | Italy | Recruiting |
| AO dei Colli - O.Monaldi | Naples | Italy | Recruiting |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06580392 on ClinicalTrials.gov ↗ ← All trials in Italy